E. Jon Jacobsen - Concepedia

Concepedia

Author

E. Jon Jacobsen

Pfizer (United States)

Also Known As

E J Jacobsen, E Jon Jacobsen, E. J. JACOBSEN, E. J. Jacobsen, E. Jacobsen, E. Jon Jacobsen, E. Jon. Jacobsen, E.J. Jacobsen, E.Jon Jacobsen

71

Publications

3.1K

Citations

29

H-Index

70

Concepts

All Affiliations

Pfizer (United States)W.E. Upjohn Institute for Employment Research Pfizer (United Kingdom)University of California, Irvine

EJ

About

E. Jon Jacobsen is an author at Pfizer (United States) specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	27	1.6K
2	Natural Sciences	16	19	1.1K
3	Engineering	7	7	376
4	Social Sciences	3	3	220
5	Health Sciences	1	1	32

E. Jon Jacobsen

×

46

Publications

3.1K

Citations

29

H-Index

	Year	Citations
Novel 21-amino steroids as potent inhibitors of iron-dependent lipid peroxidation. J. Mark Braughler, Jeffery F. Pregenzer, R L Chase, Journal of Biological Chemistry	1987	469
Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6 Jill Chrencik, Akshay Patny, Iris Leung, Journal of Molecular Biology Protein FunctionSignal TransductionBiochemistryBiomolecular Structure PredictionProtein Folding	2010	224
Salen-Manganese Complexes Are Superoxide Dismutase-Mimics Michel Baudry, Annadora J. Bruce, Michael Palucki, Biochemical and Biophysical Research Communications Inorganic ChemistryBiochemistryNatural SciencesMolecular BiologyReactive Oxygen Specie	1993	208
Discovery of<i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship Donn G. Wishka, Daniel P. Walker, Karen M. Yates, Journal of Medicinal Chemistry NeuropsychologyCompound 14PsychopharmacologyPharmacotherapySocial Sciences	2006	188
U-78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. Edward D. Hall, J. Mark Braughler, Patricia A. Yonkers, Journal of Pharmacology and Experimental Therapeutics	1991	152
The 21-aminosteroids: Potent inhibitors of lipid peroxidation for the treatment of central nervous system trauma and ischemia J. Mark Braughler, Edward D. Hall, E. Jon Jacobsen, Drugs of the Future Reperfusion InjuryMedicineLipid PeroxidationNeuropharmacologyVascular Biology	1989	128
The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes John E. Tavis, Xiaohong Cheng, Yuan Hu, PLoS Pathogens	2013	108
Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals Chun Wang, Susan L. Hockerman, E. Jon Jacobsen, The Journal of Experimental Medicine	2018	98
Design, synthesis, structure–activity relationship, and in vivo activity of azabicyclic aryl amides as α7 nicotinic acetylcholine receptor agonists Daniel P. Walker, Donn G. Wishka, David W. Piotrowski, Bioorganic & Medicinal Chemistry Structure–activity RelationshipVivo ActivityBiochemistryMedicineRational Drug Design	2006	94
3-Phenyl-Substituted Imidazo[1,5-<i>a</i>]quinoxalin-4-ones and Imidazo[1,5-<i>a</i>]quinoxaline Ureas That Have High Affinity at the GABA<sub>A</sub>/Benzodiazepine Receptor Complex E. Jon Jacobsen, Lindsay S. Stelzer, Kenneth L. Belonga, Journal of Medicinal Chemistry Drug TargetPharmacotherapyChemical BiologyPharmaceutical ChemistryDrug Resistance	1996	91

Page 1